Announcements Trials
Browse Landscape

Phase

Phase 2 199Phase 1 89Phase 3 73Phase 1/2 40Phase 4 7Phase NA 5Phase 2/3 5Phase EARLY_PHASE1 1

Status

Recruiting 8Unknown 5Completed 5Terminated 3Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5Other solid neoplasm 3

Conditions

Mesothelioma 3NSCLC 1Mesothelioma, Malignant 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Pemetrexed × Clear all
NCT04619797 2026-02-03

SKYSCRAPER-06

Hoffmann-La Roche

Phase 2/3 Completed
542 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02784171 2024-12-10

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

Canadian Cancer Trials Group

Phase 2/3 Completed
520 enrolled 16 charts 1 FDA
Other solid neoplasmThoracic

Mesothelioma

NCT02709512 2023-10-04

ATOMIC

Polaris Group

Phase 2/3 Completed
249 enrolled 17 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT00651456 2023-03-13

MAPS

Intergroupe Francophone de Cancerologie Thoracique

Phase 2/3 Completed
448 enrolled
Other solid neoplasmThoracic

Mesothelioma

NCT01769066 2016-02-23

Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC

Fudan University

Phase 2/3 Completed
117 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡